• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Effect of a direct thrombin inhibitor compared with dalteparin and unfractionated heparin on human osteoblasts.

作者信息

Winkler Tobias, Perka Carsten, Matziolis Dörte, Matziolis Georg

机构信息

Center of Musculoskeletal Surgery, Berlin Brandenburg Center for Regenerative Medicine, Charité - Universitaetsmedizin Berlin, Germany.

出版信息

Open Orthop J. 2011 Mar 16;5:52-8. doi: 10.2174/1874325001105010052.

DOI:10.2174/1874325001105010052
PMID:21552458
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3087215/
Abstract

PURPOSE

Osteoporosis is a relevant problem after long term administration of unfractionated heparin (UFH) and low molecular weight heparin. Melagatran is a representative of a new group of direct thrombin inhibitors with comparable data in the prevention of thromboembolic events after orthopaedic surgery. The aim of our in vitro study was to investigate the effect of a direct thrombin inhibitor compared with dalteparin and UFH on human osteoblasts.

MATERIALS AND METHODS

Melagatran, dalteparin and UFH were added to primary osteoblast cultures in their therapeutic range and two decimal powers below and above. Cell number, protein synthesis, mitochondrial and alkaline phosphatase activity and collagen type I synthesis were evaluated.

RESULTS

Melagatran showed the least influence on protein synthesis and cell proliferation with a reduction of cell number to 83.5 ± 9% (p = 0.027) of the control group only in the highest investigated concentration after 15 days of incubation. Mitochondrial and alkaline phosphatase activity and collagen type I synthesis in osteoblasts incubated with melagatran and dalteparin showed similar patterns. UFH showed the most pronounced influence on cellular metabolism.

CONCLUSIONS

Melagatran showed less inhibitory in vitro effects on human osteoblasts than dalteparin or UFH. The presented study gives first hints that direct thrombin inhibitors may help prevent heparin-induced negative effects on bone metabolism.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61fb/3087215/552aee6c02b9/TOORTHJ-5-52_F7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61fb/3087215/fd53361f16cf/TOORTHJ-5-52_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61fb/3087215/f888ee6cc3bc/TOORTHJ-5-52_F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61fb/3087215/cb49a77b9d45/TOORTHJ-5-52_F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61fb/3087215/f8c63068ce59/TOORTHJ-5-52_F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61fb/3087215/16c241f18e69/TOORTHJ-5-52_F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61fb/3087215/fbbb687b0691/TOORTHJ-5-52_F6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61fb/3087215/552aee6c02b9/TOORTHJ-5-52_F7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61fb/3087215/fd53361f16cf/TOORTHJ-5-52_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61fb/3087215/f888ee6cc3bc/TOORTHJ-5-52_F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61fb/3087215/cb49a77b9d45/TOORTHJ-5-52_F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61fb/3087215/f8c63068ce59/TOORTHJ-5-52_F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61fb/3087215/16c241f18e69/TOORTHJ-5-52_F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61fb/3087215/fbbb687b0691/TOORTHJ-5-52_F6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61fb/3087215/552aee6c02b9/TOORTHJ-5-52_F7.jpg

相似文献

1
Effect of a direct thrombin inhibitor compared with dalteparin and unfractionated heparin on human osteoblasts.
Open Orthop J. 2011 Mar 16;5:52-8. doi: 10.2174/1874325001105010052.
2
Effects of fondaparinux compared with dalteparin, enoxaparin and unfractionated heparin on human osteoblasts.磺达肝癸钠与达肝素、依诺肝素及普通肝素相比对人成骨细胞的影响。
Calcif Tissue Int. 2003 Oct;73(4):370-9. doi: 10.1007/s00223-002-2091-5. Epub 2003 Jul 24.
3
Effect of low molecular weight heparin (dalteparin) and fondaparinux (Arixtra) on human osteoblasts in vitro.低分子量肝素（达肝素）和磺达肝癸钠（安卓）对人成骨细胞的体外作用。
Br J Surg. 2005 Feb;92(2):177-83. doi: 10.1002/bjs.4809.
4
Paradoxical enhancement of the intrinsic pathway-induced thrombin generation in human plasma by melagatran, a direct thrombin inhibitor, but not edoxaban, a direct factor Xa inhibitor, or heparin.直接凝血酶抑制剂美拉加群可使人体血浆中内源性途径诱导的凝血酶生成出现矛盾性增强，而直接Xa因子抑制剂依度沙班或肝素则不会。
Thromb Res. 2015 Sep;136(3):658-62. doi: 10.1016/j.thromres.2015.06.034. Epub 2015 Jul 4.
5
Effects of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, and dalteparin on the endogenous thrombin potential in venous blood from healthy male subjects.口服直接凝血酶抑制剂希美加群的活性形式美拉加群和达肝素对健康男性受试者静脉血中内源性凝血酶潜力的影响。
Blood Coagul Fibrinolysis. 2003 Jul;14(5):457-62. doi: 10.1097/00001721-200307000-00005.
6
A dose-ranging study of the oral direct thrombin inhibitor, ximelagatran, and its subcutaneous form, melagatran, compared with dalteparin in the prophylaxis of thromboembolism after hip or knee replacement: METHRO I. MElagatran for THRombin inhibition in Orthopaedic surgery.口服直接凝血酶抑制剂希美加群及其皮下注射剂型美拉加群与达肝素预防髋或膝关节置换术后血栓栓塞的剂量范围研究：METHRO I。美拉加群在骨科手术中抑制凝血酶。
Thromb Haemost. 2002 Feb;87(2):231-7.
7
Rebound thrombin generation after heparin therapy in unstable angina. A randomized comparison between unfractionated and low-molecular-weight heparin.不稳定型心绞痛患者肝素治疗后的凝血酶生成反弹。普通肝素与低分子量肝素的随机对照研究。
J Am Coll Cardiol. 2002 Mar 6;39(5):811-7. doi: 10.1016/s0735-1097(01)01825-3.
8
Comparative effects of unfractionated heparin and low molecular weight heparin on vascular endothelial cell tissue factor pathway inhibitor release: a model for assessing intrinsic thromboresistance.普通肝素与低分子量肝素对血管内皮细胞组织因子途径抑制物释放的比较效应：一种评估内源性抗血栓形成能力的模型
J Thromb Thrombolysis. 2002 Oct;14(2):123-9. doi: 10.1023/a:1023280811804.
9
Differential effect of the low-molecular-weight heparin, dalteparin, and unfractionated heparin on microvascular endothelial cell hemostatic properties.低分子量肝素达肝素与普通肝素对微血管内皮细胞止血特性的不同作用
Haematologica. 2006 Feb;91(2):207-14.
10
Low molecular weight heparin (dalteparin) is equally effective as unfractionated heparin in reducing coagulation activity and perfusion abnormalities during the early treatment of pulmonary embolism.低分子量肝素（达肝素）在肺栓塞早期治疗中，在降低凝血活性和灌注异常方面与普通肝素同样有效。
J Lab Clin Med. 2004 Aug;144(2):100-7. doi: 10.1016/j.lab.2004.04.006.

引用本文的文献

1
Identification of potential cell death-related biomarkers for diagnosis and treatment of osteoporosis.鉴定骨质疏松症诊断和治疗相关的潜在细胞死亡生物标志物。
BMC Musculoskelet Disord. 2024 Mar 25;25(1):235. doi: 10.1186/s12891-024-07349-6.
2
Effect of direct oral anticoagulant dabigatran on early bone healing: An experimental study in rats.直接口服抗凝剂达比加群对早期骨愈合的影响：一项大鼠实验研究
J Adv Periodontol Implant Dent. 2023 Nov 7;15(2):86-92. doi: 10.34172/japid.2023.020. eCollection 2023.
3
Hirudin promotes proliferation and osteogenic differentiation of HBMSCs via activation of cyclic guanosine monophosphate (cGMP)/protein kinase-G (PKG) signaling pathway.

本文引用的文献

1
Ximelagatran--a promising new drug in thromboembolic disorders.
Curr Pharm Des. 2005;11(4):527-38. doi: 10.2174/1381612053382016.
2
Ximelagatran: a novel oral direct thrombin inhibitor for long-term anticoagulation.
Rev Cardiovasc Med. 2004 Spring;5(2):99-103.
3
The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study.直接凝血酶抑制剂美拉加群序贯口服希美加群与依诺肝素预防全髋关节或全膝关节置换术后静脉血栓栓塞的比较：EXPRESS研究
J Thromb Haemost. 2003 Dec;1(12):2490-6. doi: 10.1111/j.1538-7836.2003.00494.x.
4
水蛭素通过激活环鸟苷酸单磷酸（cGMP）/蛋白激酶 G（PKG）信号通路促进 HBMSCs 的增殖和成骨分化。
Bioengineered. 2022 Mar;13(3):6061-6069. doi: 10.1080/21655979.2021.2008697.
4
Anticoagulants and Osteoporosis.抗凝血剂与骨质疏松症。
Int J Mol Sci. 2019 Oct 24;20(21):5275. doi: 10.3390/ijms20215275.
5
The Effect of Low Molecular Weight Heparins on Fracture Healing.低分子量肝素对骨折愈合的影响。
Open Orthop J. 2015 Jun 26;9:226-36. doi: 10.2174/1874325001509010226. eCollection 2015.
Changes in bone density during long-term administration of low-molecular-weight heparins or acenocoumarol for secondary prophylaxis of venous thromboembolism.长期使用低分子量肝素或醋硝香豆素进行静脉血栓栓塞症二级预防期间的骨密度变化。
Pathophysiol Haemost Thromb. 2003 Mar-Apr;33(2):64-7. doi: 10.1159/000073848.
5
Effects of fondaparinux compared with dalteparin, enoxaparin and unfractionated heparin on human osteoblasts.磺达肝癸钠与达肝素、依诺肝素及普通肝素相比对人成骨细胞的影响。
Calcif Tissue Int. 2003 Oct;73(4):370-9. doi: 10.1007/s00223-002-2091-5. Epub 2003 Jul 24.
6
Clinical experience of melagatran/ximelagatran in major orthopaedic surgery.
Thromb Res. 2003 Jul 15;109 Suppl 1:S23-9. doi: 10.1016/s0049-3848(03)00248-2.
7
[Serious complication after subcutaneous injection of heparin for prophylaxis of thromboembolism. Case report].[皮下注射肝素预防血栓栓塞后的严重并发症。病例报告]
Unfallchirurg. 2003 Feb;106(2):182-3. doi: 10.1007/s00113-002-0494-4.
8
[Influence of unfractionated and low-molecular-weight heparin on bone healing: an animal model].[普通肝素和低分子量肝素对骨愈合的影响：动物模型]
Unfallchirurg. 2002 Sep;105(9):791-6. doi: 10.1007/s00113-002-0419-2.
9
Quantification of histochemical staining by color deconvolution.通过颜色反卷积对组织化学染色进行定量分析。
Anal Quant Cytol Histol. 2001 Aug;23(4):291-9.
10
A histomorphometric evaluation of heparin-induced bone loss after discontinuation of heparin treatment in rats.
Blood. 1999 Feb 15;93(4):1231-6.